# WinVest Acquisition Corp.: financial statements, quarterly

WINV · OTC · CIK 1854463 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/winv.md) · [Financials](/companies/winv/financials.md) · [Filings](/companies/winv/filings.md) · [Insiders](/companies/winv/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/winv/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating income | $k | [(257)](/filings/0001493152-24-045891.md) | [(288) d](/filings/0001493152-25-009315.md) | [(225)](/filings/0001493152-26-005099.md) | [(553)](/filings/0001493152-26-005102.md) | [(946)](/filings/0001493152-26-005937.md) | [(848) d](/filings/0001493152-26-013671.md) | [(730)](/filings/0001493152-26-023144.md) | [(314)](/filings/0001493152-26-038050.md) | [(319)](/filings/0001493152-26-005937.md) | [(137) d](/filings/0001493152-26-013671.md) | [(183)](/filings/0001493152-26-023144.md) | [(125)](/filings/0001493152-26-038050.md) |
| Income tax | $k | [14.0](/filings/0001493152-24-045891.md) | [36.0 d](/filings/0001493152-25-009315.md) | [24.0](/filings/0001493152-26-005099.md) | [29.0](/filings/0001493152-26-005102.md) | [11.0](/filings/0001493152-26-005937.md) | [16.0 d](/filings/0001493152-26-013671.md) | [4.0](/filings/0001493152-26-023144.md) | [3.0](/filings/0001493152-26-038050.md) | [4.0](/filings/0001493152-26-005937.md) | [2.0 d](/filings/0001493152-26-013671.md) | [2.0](/filings/0001493152-26-023144.md) | [2.0](/filings/0001493152-26-038050.md) |
| Net income | $k | [(104)](/filings/0001493152-24-045891.md) | [(181) d](/filings/0001493152-25-009315.md) | [(106)](/filings/0001493152-26-005937.md) | [(440)](/filings/0001493152-26-005937.md) | [(884)](/filings/0001493152-26-005937.md) | [(802) d](/filings/0001493152-26-013671.md) | [(709)](/filings/0001493152-26-038050.md) | [(292)](/filings/0001493152-26-038050.md) | [(296)](/filings/0001493152-26-005937.md) | [(118) d](/filings/0001493152-26-013671.md) | [(166)](/filings/0001493152-26-038050.md) | [(109)](/filings/0001493152-26-038050.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.0](/filings/0001493152-23-042186.md) | [0.0](/filings/0001493152-25-009315.md) | [0.1](/filings/0001493152-24-020904.md) | [0.0](/filings/0001493152-24-031674.md) | [0.0](/filings/0001493152-24-045891.md) | [0.0](/filings/0001493152-26-013671.md) | [0.0](/filings/0001493152-26-005099.md) | not reported | not reported | [0.0](/filings/0001493152-26-038050.md) | [0.0](/filings/0001493152-26-023144.md) | [0.0](/filings/0001493152-26-038050.md) |
| Current assets | $m | [0.1](/filings/0001493152-23-042186.md) | [0.3](/filings/0001493152-25-009315.md) | [0.2](/filings/0001493152-24-020904.md) | [0.2](/filings/0001493152-24-031674.md) | [0.1](/filings/0001493152-24-045891.md) | [0.2](/filings/0001493152-26-013671.md) | [0.2](/filings/0001493152-26-005099.md) | [0.2](/filings/0001493152-26-005102.md) | [0.1](/filings/0001493152-26-005937.md) | [0.1](/filings/0001493152-26-038050.md) | [0.2](/filings/0001493152-26-023144.md) | [0.1](/filings/0001493152-26-038050.md) |
| Total assets | $m | [14.1](/filings/0001493152-23-042186.md) | [12.7](/filings/0001493152-25-009315.md) | [12.9](/filings/0001493152-24-020904.md) | [5.8](/filings/0001493152-24-031674.md) | [5.9](/filings/0001493152-24-045891.md) | [3.3](/filings/0001493152-26-013671.md) | [3.4](/filings/0001493152-26-005099.md) | [3.5](/filings/0001493152-26-005102.md) | [3.1](/filings/0001493152-26-005937.md) | [3.2](/filings/0001493152-26-038050.md) | [3.0](/filings/0001493152-26-023144.md) | [3.1](/filings/0001493152-26-038050.md) |
| Current liabilities | $m | [2.9](/filings/0001493152-23-042186.md) | [3.0](/filings/0001493152-25-009315.md) | [3.3](/filings/0001493152-24-020904.md) | [4.1](/filings/0001493152-24-031674.md) | [5.0](/filings/0001493152-24-045891.md) | [6.0](/filings/0001493152-26-013671.md) | [6.8](/filings/0001493152-26-005099.md) | [7.2](/filings/0001493152-26-005102.md) | [7.6](/filings/0001493152-26-005937.md) | [7.8](/filings/0001493152-26-038050.md) | [8.0](/filings/0001493152-26-023144.md) | [8.2](/filings/0001493152-26-038050.md) |
| Total liabilities | $m | [6.9](/filings/0001493152-23-042186.md) | [7.0](/filings/0001493152-25-009315.md) | [7.3](/filings/0001493152-24-020904.md) | [8.1](/filings/0001493152-24-031674.md) | [9.0](/filings/0001493152-24-045891.md) | [10.0](/filings/0001493152-26-013671.md) | [10.8](/filings/0001493152-26-005099.md) | [11.2](/filings/0001493152-26-005102.md) | [11.6](/filings/0001493152-26-005937.md) | [11.8](/filings/0001493152-26-038050.md) | [12.0](/filings/0001493152-26-023144.md) | [12.2](/filings/0001493152-26-038050.md) |
| Shareholders' equity | $m | [(6.8)](/filings/0001493152-24-045891.md) | [(6.7)](/filings/0001493152-26-013671.md) | [(7.1)](/filings/0001493152-26-005937.md) | [(7.9)](/filings/0001493152-26-005937.md) | [(9.0)](/filings/0001493152-26-005937.md) | [(9.9)](/filings/0001493152-26-038050.md) | [(10.8)](/filings/0001493152-26-038050.md) | [(11.2)](/filings/0001493152-26-038050.md) | [(11.6)](/filings/0001493152-26-005937.md) | [(11.8)](/filings/0001493152-26-038050.md) | [(11.9)](/filings/0001493152-26-038050.md) | [(12.2)](/filings/0001493152-26-038050.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(23.8) d](/filings/0001493152-24-045891.md) | [(713) d](/filings/0001493152-25-009315.md) | [(99.9)](/filings/0001493152-26-005099.md) | [(450) d](/filings/0001493152-26-005102.md) | [(230) d](/filings/0001493152-26-005937.md) | [(195) d](/filings/0001493152-26-013671.md) | [(218)](/filings/0001493152-26-023144.md) | [(91.5) d](/filings/0001493152-26-038050.md) | [(87.6) d](/filings/0001493152-26-005937.md) | [(87.0) d](/filings/0001493152-26-013671.md) | [(251)](/filings/0001493152-26-023144.md) | [(40.9) d](/filings/0001493152-26-038050.md) |
| Share repurchases | $k | not reported | [1,323 d](/filings/0001493152-25-009315.md) | not reported | not reported | [0.0 d](/filings/0001493152-26-005937.md) | [2,801 d](/filings/0001493152-26-013671.md) | not reported | not reported | [511 d](/filings/0001493152-26-005937.md) | [0.0 d](/filings/0001493152-26-013671.md) | [192](/filings/0001493152-26-023144.md) | [0.0 d](/filings/0001493152-26-038050.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2021-06-30) | Q3 FY2022 (2021-09-30) | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [2,500](/filings/0001493152-22-022405.md) | [4,402](/filings/0001493152-22-032491.md) | [2,875](/filings/0001493152-23-018472.md) | [2,875](/filings/0001493152-22-022405.md) | [2,875](/filings/0001493152-22-032491.md) | [2,875](/filings/0001493152-23-018472.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 3,080,950 at 2026-08-10, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-038050.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.